Literature DB >> 28666936

Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes.

Misawa Niki Ishii1, Koji Yamamoto2, Masanobu Shoji2, Asano Asami2, Yuji Kawamata2.   

Abstract

Accurate risk assessment for drug-induced seizure is expected to be performed before entering clinical studies because of its severity and fatal damage to drug development. Induced pluripotent stem cell (iPSC) technology has allowed the use of human neurons and glial cells in toxicology studies. Recently, several studies showed the advantage of co-culture system of human iPSC (hiPSC)-derived neurons with rodent/human primary astrocytes regarding neuronal functions. However, the application of hiPSC-derived neurons for seizure risk assessment has not yet been fully addressed, and not at all when co-cultured with hiPSC-derived astrocytes. Here, we characterized hiPSC-derived neurons co-cultured with hiPSC-derived astrocytes to discuss how hiPSC-derived neurons are useful to assess seizure risk of drugs. First, we detected the frequency of spikes and synchronized bursts hiPSC-derived neurons when co-cultured with hiPSC-derived astrocytes for 8 weeks. This synchronized burst was suppressed by the treatment with 6-cyano-7-nitroquinoxaline-2,3-dione, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist, and D-(-)-2-amino-5-phosphonopentanoic acid, an N-Methyl-d-aspartate (NMDA) receptor antagonist. These data suggested that co-cultured hiPSC-derived neurons formed synaptic connections mediated by AMPA and NMDA receptors. We also demonstrated that co-cultured hiPSC-derived neurons showed epileptiform activity upon treatment with gabazine or kaliotoxin. Finally, we performed single-cell transcriptome analysis in hiPSC-derived neurons and found that hiPSC-derived astrocytes activated the pathways involved in the activities of AMPA and NMDA receptor functions, neuronal polarity, and axon guidance in hiPSC-derived neurons. These data suggested that hiPSC-derived astrocytes promoted the development of action potential, synaptic functions, and neuronal networks in hiPSC-derived neurons, and then these functional alterations result in the epileptiform activity in response to convulsant drugs. Our study indicates the possibility that co-culture system of hiPSC-derived neurons with hiPSC-derived astrocytes could be useful in the risk assessment of drug-induced seizure.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epileptiform activity; Neuronal networks; Single-cell transcriptome; hiPSC-derived astrocytes; hiPSC-derived neurons

Mesh:

Substances:

Year:  2017        PMID: 28666936     DOI: 10.1016/j.tox.2017.06.010

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  16 in total

Review 1.  Neurotoxicity of pesticides.

Authors:  Jason R Richardson; Vanessa Fitsanakis; Remco H S Westerink; Anumantha G Kanthasamy
Journal:  Acta Neuropathol       Date:  2019-06-13       Impact factor: 17.088

Review 2.  Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

Authors:  Arun Sharma; Samuel Sances; Michael J Workman; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2020-03-05       Impact factor: 24.633

3.  A human stem cell-derived test system for agents modifying neuronal N-methyl-D-aspartate-type glutamate receptor Ca2+-signalling.

Authors:  Stefanie Klima; Markus Brüll; Anna-Sophie Spreng; Ilinca Suciu; Tjalda Falt; Jens C Schwamborn; Tanja Waldmann; Christiaan Karreman; Marcel Leist
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

Review 4.  Astrocytes as targets for drug discovery.

Authors:  Kirill Gorshkov; Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Drug Discov Today       Date:  2018-01-06       Impact factor: 7.851

Review 5.  In vitro Models for Seizure-Liability Testing Using Induced Pluripotent Stem Cells.

Authors:  Alastair I Grainger; Marianne C King; David A Nagel; H Rheinallt Parri; Michael D Coleman; Eric J Hill
Journal:  Front Neurosci       Date:  2018-08-31       Impact factor: 4.677

6.  Impact of Sleep-Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons.

Authors:  Remi Yokoi; Miho Okabe; Naoki Matsuda; Aoi Odawara; Akihiro Karashima; Ikuro Suzuki
Journal:  Front Neurosci       Date:  2019-05-29       Impact factor: 4.677

Review 7.  Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes.

Authors:  Mika Suga; Takayuki Kondo; Haruhisa Inoue
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 8.  Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events.

Authors:  Elena Genova; Federica Cavion; Marianna Lucafò; Luigina De Leo; Marco Pelin; Gabriele Stocco; Giuliana Decorti
Journal:  World J Stem Cells       Date:  2019-12-26       Impact factor: 5.326

Review 9.  Progress in the molecular mechanisms of genetic epilepsies using patient-induced pluripotent stem cells.

Authors:  Ruijiao Zhou; Guohui Jiang; Xin Tian; Xuefeng Wang
Journal:  Epilepsia Open       Date:  2018-07-08

10.  Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system.

Authors:  A Odawara; N Matsuda; Y Ishibashi; R Yokoi; I Suzuki
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.